Market Place
Sourcing Support
Enforcement Report - Week of October 23, 2024
23 Oct 2024 //
FDA
Acquired approval for manufacturing and marketing generic drugs
15 Aug 2024 //
PRESS RELEASE
FY2024 Supplementary Material of Financial Results 1Q
08 Aug 2024 //
PRESS RELEASE
Notice of Financial Results of Parent Company, etc.
25 Jun 2024 //
PRESS RELEASE
NHI Drug Price List Updated With Three Ingredients & 7 Generics
13 Jun 2024 //
PRESS RELEASE
FY2023 Supplementary Material of Financial Results
14 May 2024 //
PRESS RELEASE
Summary of Consolidated Financial Results for the Year Ended March 31, 2024
14 May 2024 //
PRESS RELEASE
N-Nitroso Duloxetine Analytical Method Published in ACS Omega
15 Mar 2024 //
PRESS RELEASE
Manufacturing and Marketing Approval for Three Ingredients and Eight Items
15 Feb 2024 //
PRESS RELEASE
Approval Granted For Additional Manufacturing Plant For Esomeprazole Capsules
14 Feb 2024 //
PRESS RELEASE
FY2023 3Q Supplementary Material of Financial Results
13 Feb 2024 //
PRESS RELEASE
Chugai Pharma & Towa Pharma introduce Edirol tablet for osteoporosis treatment
10 Dec 2022 //
PHARMABIZ
Japan approves Chugai Pharma`s osteoporosis drug
16 Aug 2022 //
BIOSPECTRUMASIA
Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration
18 Feb 2021 //
PRNASIA
Towa Completes Acquisition of Esteve`s Generic Division
31 Jan 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.